glp 1 and working out GLP-1 vs. Exercise: Two Paths to Weight Loss GLP-1 and Strength Training: Avoid

LifeRx has a transparency problem that starts with pricing and extends to its marketing

Effective data-driven approaches include: Predictive analytics allow PBMs to intervene before high-cost specialty utilization becomes unmanaged spend Biosimilar opportunity identification requires drug-level data that most PBMs don't surface Claims patterns can reveal clinical gaps, adherence risks and cost optimization opportunities The next wave of specialty cost management will be driven by how well programs use data to act, not just report 2

A typical taper from 12mg might step down to 8mg for two weeks, then 4mg for two weeks, then 2mg for two weeks before stopping entirely

That distinction matters for compounding conversations

Neither the brand-name versions, Zepbound and Mounjaro, nor compounded tirzepatide is ever legally available without a prescription

The research team is looking for individuals who (a) are at least 18 years of age or older, (b) live in the United States, and (c) are currently taking a GLP-1 medication for weight loss and have taken it without interruption for the six consecutive months immediately prior to study enrollment